---

---

United States
Securities and Exchange Commission
Washington, D.C. 20549


FORM 8-K


Current Report Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934


February 17, 2010
(Date of Report)


ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)

(315) 332-7100
(Registrant’s telephone number, including area code)

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

---

---

Item 1.01           Entry into a Material Definitive Agreement

On February 17, 2010, Ultralife Corporation (the “Company”), together with the Company’s U.S. subsidiaries (collectively, the “Borrowers”), entered into a senior secured asset based revolving credit facility of up to $35.0 million with RBS Business Capital, a division of RBS Asset Finance, Inc. (“RBS”) (the “Credit Facility”).  The proceeds from the Credit Facility can be used for general working capital purposes, general corporate purposes, letter of credit foreign exchange support and to repay existing indebtedness under the Previous Credit Facility.  The Credit Facility has a maturity date of February 17, 2013 (the “Maturity Date”).  The Credit Facility is secured by substantially all of the Company’s assets.  The Company paid RBS a facility fee of $262,500.  

On February 18, 2010, the Company drew down $9.87 million from the Credit Facility to repay all outstanding amounts due under the Amended and Restated Credit Agreement (the “Previous Credit Facility”) with JPMorgan Chase Bank, N.A. and Manufacturers Traders Trust Company, with JPMorgan Chase Bank, N.A. acting as the administrative agent.  The Company’s available borrowing under the Credit Facility fluctuates from time to time based upon amounts of eligible accounts receivable and eligible inventory.

Available borrowings under the Credit Facility equals (1) the lesser of $35.0 million or (2) 85% of eligible accounts receivable plus the lesser of (a) up to 70% of the book value of the Company’s eligible inventory or (b) 85% of the appraised net orderly liquidation value of the Company’s eligible inventory.  The borrowing base under the Credit Facility is further reduced by (1) the face amount of any letters of credit outstanding, (2) any liabilities of the Company under hedging contracts with RBS and (3) the value of any reserves as deemed appropriate by RBS.  The Company is required to have at least $3.0 million available under the Credit Facility at all times.  Subject to obtaining certain third party consents (which were not required to close the Credit Facility), the Company’s cash and available borrowing after repayment of the Previous Credit Facility would be approximately $13.4 million.

Interest will accrue on outstanding indebtedness under the Credit Facility at one of two LIBOR rates plus 4.50%.  Upon delivery of our audited financial statements for the fiscal year ended December 31, 2010 to RBS, and assuming no events of default exist at such time, the rate of interest under the Credit Facility can fluctuate based on the available borrowings remaining under the Credit Facility as set forth in the following table:

In addition to paying interest on the outstanding principal under the Credit Facility, the Company is required to pay an unused line fee of 0.50% on the unused portion of the $35.0 million Credit Facility.  The Company must also pay customary letter of credit fees equal to the LIBOR rate and the applicable margin and any other customary fees or expenses of the issuing bank.

Interest that accrues under the Credit Facility is to be paid monthly with all outstanding principal, interest and applicable fees due on the Maturity Date.

The Company is required to maintain a fixed coverage ratio of 1.20 to 1.00 or greater at all times after March 28, 2010.  All borrowings under the Credit Facility are subject to the satisfaction of customary conditions, including the absence of an event of default and accuracy of the Borrowers’ representations and warranties.  The Credit Facility also includes customary representations and warranties, affirmative covenants and events of default.  If an event default occurs, RBS would be entitled to take various actions, including accelerating the amount due under the Credit Facility, and all actions permitted to be taken by a secured creditor.

The Company anticipates that it will file a copy of the Credit Facility with its Annual Report on Form 10-K for the fiscal year ended December 31, 2009.

Item 1.02           Termination of a Material Definitive Agreement

The information provided under Item 1.01 of this Current Report on Form 8-K regarding the repayment of the Previous Credit Facility, is incorporated by reference into this Item 1.02.

Item 2.03           Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

The information provided under Item 1.01 of this Current Report on Form 8-K regarding the Credit Facility, is incorporated by reference into this Item 2.03.

Item 9.01           Financial Statements and Exhibits

(d)  Exhibits.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit 99.1

Ultralife Corporation Closes $35 Million Revolving Credit Facility with RBS Business Capital

NEWARK, N.Y.--(BUSINESS WIRE)--February 18, 2010--Ultralife Corporation (NASDAQ: ULBI) has closed on a three-year $35 million senior secured asset-based revolving credit facility, effective February 17, 2010, with RBS Business Capital (“RBS”), a division of Citizens Financial Group. This revolving credit facility replaces the company’s $35 million senior secured revolving credit facility with JPMorgan Chase Bank, N.A. and Manufacturers and Traders Trust Company.

The opening balance under the facility is $10 million. Borrowings under the facility will bear interest based on LIBOR plus 450 basis points through the end of 2010 after which the basis point spread may vary depending on the company meeting certain financial criteria.

“This asset-based facility meets our objective of securing credit arrangements that match our operating needs and meet our global financing requirements. We appreciate the support provided to us by RBS and look forward to maintaining a constructive lender relationship with them,” said John D. Kavazanjian, Ultralife’s president and chief executive officer.

About Ultralife Corporation

Ultralife Corporation, which began as a battery company, serves its markets with products and services ranging from portable and standby power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Ultralife’s family of brands includes: Ultralife Batteries, Stationary Power Services, RPS Power Systems, ABLE, McDowell Research, RedBlack Communications and AMTI. Ultralife’s operations are in North America, Europe and Asia. For more information, visit www.ultralifecorp.com.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include: worsening global economic conditions, increased competitive environment and pricing pressures, and the possibility of intangible asset impairment charges that may be taken should management decide to retire one or more of the brands of acquired companies. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company’s analysis only as of today’s date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife's financial results is included in Ultralife's Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

CONTACT:
Company:
Ultralife Corporation
Julius Cirin, 315-332-7100
jcirin@ultralifecorp.com
or
Investor Relations:
Lippert/Heilshorn & Associates, Inc.
Jody Burfening, 212-838-3777
jburfening@lhai.com